These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population. Yi Z; Ling Y; Zhang X; Chen J; Hu K; Wang Y; Song W; Ying T; Zhang R; Lu H; Yuan Z Emerg Microbes Infect; 2020 Dec; 9(1):1988-1996. PubMed ID: 32844713 [No Abstract] [Full Text] [Related]
26. Absence of neutralizing antibodies against the Omicron SARS-CoV-2 variant in convalescent sera from individuals infected with the ancestral SARS-CoV-2 virus or its Gamma variant. Villas-Boas LS; Paula AV; Silva ARD; Paiao HGO; Tozetto-Mendoza TR; Manuli ER; Leal FE; Ferraz ABC; Sabino EC; Bierrenbach AL; Witkin SS; Mendes-Correa MC Clinics (Sao Paulo); 2022; 77():100068. PubMed ID: 35767900 [TBL] [Abstract][Full Text] [Related]
27. Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion. Ren W; Ju X; Gong M; Lan J; Yu Y; Long Q; Kenney DJ; O'Connell AK; Zhang Y; Zhong J; Zhong G; Douam F; Wang X; Huang A; Zhang R; Ding Q mBio; 2022 Apr; 13(2):e0009922. PubMed ID: 35266815 [TBL] [Abstract][Full Text] [Related]
28. Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma. Tonn T; Corman VM; Johnsen M; Richter A; Rodionov RN; Drosten C; Bornstein SR Lancet Microbe; 2020 Jun; 1(2):e63. PubMed ID: 32835332 [No Abstract] [Full Text] [Related]
29. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters. Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068 [TBL] [Abstract][Full Text] [Related]
30. Control of SARS-CoV-2 infection after Spike DNA or Spike DNA+Protein co-immunization in rhesus macaques. Rosati M; Agarwal M; Hu X; Devasundaram S; Stellas D; Chowdhury B; Bear J; Burns R; Donohue D; Pessaint L; Andersen H; Lewis MG; Terpos E; Dimopoulos MA; Wlodawer A; Mullins JI; Venzon DJ; Pavlakis GN; Felber BK PLoS Pathog; 2021 Sep; 17(9):e1009701. PubMed ID: 34551020 [TBL] [Abstract][Full Text] [Related]
31. Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Strain Variation on Virus Neutralization Titers: Therapeutic Use of Convalescent Plasma. Nguyen D; Xiao J; Simmonds P; Lamikanra A; Odon V; Ratcliff J; Townsend A; Roberts DJ; Harvala H J Infect Dis; 2022 Mar; 225(6):971-976. PubMed ID: 34751775 [TBL] [Abstract][Full Text] [Related]
34. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination. Chen LL; Lu L; Choi CY; Cai JP; Tsoi HW; Chu AW; Ip JD; Chan WM; Zhang RR; Zhang X; Tam AR; Lau DP; To WK; Que TL; Yip CC; Chan KH; Cheng VC; Yuen KY; Hung IF; To KK Clin Infect Dis; 2022 May; 74(9):1623-1630. PubMed ID: 34309648 [TBL] [Abstract][Full Text] [Related]
35. Neutralizing antibody levels against SARS-CoV-2 variants of concern Delta and Omicron in vaccine breakthrough-infected blood donors. Franchini M; Focosi D; Mengoli C; Percivalle E; Sammartino JC; Ferrari A; Zani M; Glingani C; Baldanti F Transfusion; 2022 Jun; 62(6):1171-1176. PubMed ID: 35426131 [TBL] [Abstract][Full Text] [Related]
36. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? Lu L; Zhang H; Zhan M; Jiang J; Yin H; Dauphars DJ; Li SY; Li Y; He YW Sci China Life Sci; 2020 Dec; 63(12):1833-1849. PubMed ID: 33355886 [TBL] [Abstract][Full Text] [Related]
37. Convalescent plasma - this is no time for competition. Farrugia A; MacPherson J; Busch MP Transfusion; 2020 Jul; 60(7):1644-1646. PubMed ID: 32533558 [No Abstract] [Full Text] [Related]
38. Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2. Ameratunga R; Woon ST; Steele R; Lehnert K; Leung E; Brooks AES Expert Rev Clin Immunol; 2022 Jun; 18(6):557-565. PubMed ID: 35510369 [TBL] [Abstract][Full Text] [Related]